Minnesota Legislature reaches agreement on insulin programs

Sutterstock

The Minnesota House and Senate have reached an agreement over two new programs that will make insulin more affordable to uninsured and low-income residents.

On April 8, via virtual conferencing, the legislative bodies reviewed a proposal that looked at different versions of insulin bills passed before the COVID-19 shut down the state. On April 14, when the House and Senate reconvene, the bills are expected to be acted on.

The proposal creates a program that would provide a one-time, emergency supply with a monthly cost capped at $35. The program applies to those without insurance, or those who have insurance, but pay more than $75 per month for their insulin. Intended for patients in crisis and those who need insulin immediately, the program can be accessed only one-time a year.

The bill would also create a longer-term program that would provide a 90-day supply of insulin for no more than $50 for those earning less than 400 percent of the federal poverty level. The program requires insulin manufacturers to provide insulin to the program free of charge, or face a $200,000 fine.

The bill allocated money from the state’s Health Care Access Fund to pay for the administration and promotion of the programs.

1586779258